Advertisement
Singapore markets open in 5 hours 20 minutes
  • Straits Times Index

    3,144.76
    -38.85 (-1.22%)
     
  • S&P 500

    5,061.27
    -0.55 (-0.01%)
     
  • Dow

    37,853.74
    +118.63 (+0.31%)
     
  • Nasdaq

    15,894.54
    +9.52 (+0.06%)
     
  • Bitcoin USD

    62,811.62
    -535.08 (-0.84%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,820.36
    -145.17 (-1.82%)
     
  • Gold

    2,411.10
    +28.10 (+1.18%)
     
  • Crude Oil

    85.47
    +0.06 (+0.07%)
     
  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     
  • Nikkei

    38,471.20
    -761.60 (-1.94%)
     
  • Hang Seng

    16,248.97
    -351.49 (-2.12%)
     
  • FTSE Bursa Malaysia

    1,535.00
    -7.53 (-0.49%)
     
  • Jakarta Composite Index

    7,164.81
    -7,286.88 (-50.42%)
     
  • PSE Index

    6,404.97
    -157.46 (-2.40%)
     

3 Biotech Stocks That Are Ridiculously Overpriced

3 Biotech Stocks That Are Ridiculously Overpriced

Beauty is in the eye of the beholder -- and, in many cases, so is the appropriate valuation of a stock. Here's why they picked Cassava Sciences (NASDAQ: SAVA), Ocugen (NASDAQ: OCGN), and Moderna (NASDAQ: MRNA). Prosper Junior Bakiny (Cassava Sciences): Investors have been flocking to this clinical-stage biotech all year long, pushing its share price up by well over 600%.